Table 2.

Completeness of TNM registration for 21,076 patients with non-small cell lung cancer according to year of diagnosis, gender, age, and level of comorbidity

	TNM completeness		T completeness		N completeness		M completeness		Total
	% (N)	95% CI	% (N)	95% CI	% (N)	95% CI	% (N)	95% CI	N
Year of diagnosis
2004	77.2 (2594)	75.8–78.6	87.2 (2927)	86.0–88.3	80.6 (2707)	79.3–81.9	88.0 (2956)	86.9–89.1	3358
2005	75.6 (2543)	74.1–77.0	86.6 (2913)	85.4–87.7	79.7 (2681)	78.3–81.0	88.9 (2993)	87.9–90.0	3365
2006	74.0 (2549)	72.5–75.4	84.8 (2922)	83.6–86.0	78.1 (2692)	76.7–79.5	87.1 (3003)	86.0–88.2	3446
2007	76.7 (2797)	75.3–78.0	89.0 (3246)	87.9–89.9	81.5 (2974)	80.2–82.7	90.2 (3290)	89.2–91.1	3649
2008	81.0 (2903)	79.7–82.2	91.1 (3265)	90.1–92.0	85.9 (3078)	84.7–87.0	92.2 (3304)	91.3–93.0	3585
2009	82.4 (3027)	81.2–83.6	91.9 (3376)	91.0–92.8	86.8 (3190)	85.7–87.9	92.1 (3383)	91.2–92.9	3673
Gender
Female	77.6 (7605)	76.8–78.4	88.4 (8661)	87.7–89.0	82.0 (8035)	81.2–82.7	89.5 (8775)	88.9–90.1	9800
Male	78.1 (8808)	77.3–78.9	88.6 (9988)	88.0–89.2	82.4 (9287)	81.7–83.1	90.0 (10154)	89.5–90.6	11276
Age
0–39 years	83.7 (82)	75.4–90.0	89.8 (88)	82.7–94.6	87.8 (86)	80.2–93.1	95.9 (94)	90.6–98.6	98
40–59 years	82.9 (3224)	81.7–84.1	91.4 (3553)	90.5–92.3	87.1 (3384)	86.0–88.1	94.8 (3683)	94.0–95.4	3887
60–79 years	80.8 (11085)	80.2–81.5	90.5 (12413)	90.0–91.0	84.8 (11630)	84.2–85.4	91.9 (12607)	91.5–92.4	13715
≥80 years	59.9 (2022)	58.2–61.5	76.9 (2595)	75.4–78.3	65.8 (2222)	64.2–67.4	75.4 (2545)	73.9–76.8	3376
Level of comorbidity
0 81.1 (8535)	80.4–81.9	90.5 (9524)	90.0–91.1	85.1 (8953)	84.4–85.8	92.6 (9744)	92.1–93.1	10521
1–2	76.4 (5868)	75.5–77.4	87.6 (6729)	86.9–88.4	80.8 (6203)	79.9–81.7	88.2 (6775)	87.5–89.0	7678
≥3	69.9 (2010)	68.2–71.5	83.3 (2396)	81.9–84.6	75.3 (2166)	73.7–76.8	83.8 (2410)	82.4–85.1	2877
Total	77.9 (16413)	77.3–78.4	88.5 (18649)	88.1–88.9	82.2 (17322)	81.7–82.7	89.8 (18929)	89.4–90.2	21076